Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
The Journal of Biological Chemistry
|
June 16, 1995
Residues 484-508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII
J F Healey, I M Lubin, H Nakai, et al.
Biokhimiia (Moscow, Russia)
|
October 1, 1989
[Protective effect rendered by human ceruloplasmin on erythrocytes in hepatocerebral dystrophy]
E L Saenko, O V Skorobogat'ko, T I Mzhel'skaia, et al.
Vox Sanguinis
|
August 31, 2002
Molecular defects in coagulation Factor VIII and their impact on Factor VIII function
E L Saenko, N Ananyeva, D Kouiavskaia, et al.
The Journal of Biological Chemistry
|
June 1, 2000
Factor VIII C2 domain contains the thrombin-binding site responsible for thrombin-catalyzed cleavage at Arg1689
K Nogami, M Shima, K Hosokawa, et al.
Thrombosis and Haemostasis
|
February 12, 1999
Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain
R Laub, M Di Giambattista, P Fondu, et al.
Thrombosis and Haemostasis
|
February 12, 1998
Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitors
Y Sawamoto, R Prescott, D Zhong, et al.
British Journal of Haematology
|
May 31, 2001
Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r))
D David, E L Saenko, I M Santos, et al.
Immunological Investigations
|
March 1, 1994
Modulatory effects of ceruloplasmin on lymphocytes, neutrophils and monocytes of patients with altered immune status
E L Saenko, O V Skorobogat'ko, P Tarasenko, et al.
Blood
|
May 15, 1997
The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups
R Prescott, H Nakai, E L Saenko, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 12, 2002
Haemophilia A: effects of inhibitory antibodies on factor VIII functional interactions and approaches to prevent their action
E L Saenko, N M Ananyeva, D V Kouiavskaia, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
The Journal of Biological Chemistry
|
June 16, 1995
Residues 484-508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII
J F Healey, I M Lubin, H Nakai, et al.
Biokhimiia (Moscow, Russia)
|
October 1, 1989
[Protective effect rendered by human ceruloplasmin on erythrocytes in hepatocerebral dystrophy]
E L Saenko, O V Skorobogat'ko, T I Mzhel'skaia, et al.
Vox Sanguinis
|
August 31, 2002
Molecular defects in coagulation Factor VIII and their impact on Factor VIII function
E L Saenko, N Ananyeva, D Kouiavskaia, et al.
The Journal of Biological Chemistry
|
June 1, 2000
Factor VIII C2 domain contains the thrombin-binding site responsible for thrombin-catalyzed cleavage at Arg1689
K Nogami, M Shima, K Hosokawa, et al.
Thrombosis and Haemostasis
|
February 12, 1999
Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain
R Laub, M Di Giambattista, P Fondu, et al.
Thrombosis and Haemostasis
|
February 12, 1998
Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitors
Y Sawamoto, R Prescott, D Zhong, et al.
British Journal of Haematology
|
May 31, 2001
Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r))
D David, E L Saenko, I M Santos, et al.
Immunological Investigations
|
March 1, 1994
Modulatory effects of ceruloplasmin on lymphocytes, neutrophils and monocytes of patients with altered immune status
E L Saenko, O V Skorobogat'ko, P Tarasenko, et al.
Blood
|
May 15, 1997
The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups
R Prescott, H Nakai, E L Saenko, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 12, 2002
Haemophilia A: effects of inhibitory antibodies on factor VIII functional interactions and approaches to prevent their action
E L Saenko, N M Ananyeva, D V Kouiavskaia, et al.
Page
of 6